Rolf Karl Richard Nilsson
Keine laufenden Positionen mehr
Profil
Rolf Karl Richard Nilsson formerly worked at Arterion AB, as Chief Executive Officer from 2007 to 2013, Acosense AB, as Chief Executive Officer from 2019 to 2022, and Parans Solar Lighting AB, as Chief Technical Officer from 2015 to 2017.
Mr. Nilsson received his graduate degree from Chalmers University of Technology.
Ehemalige bekannte Positionen von Rolf Karl Richard Nilsson
| Unternehmen | Position | Ende |
|---|---|---|
| ACOSENSE AB (PUBL) | Vorstandsvorsitzender | 01.07.2022 |
| PARANS SOLAR LIGHTING AB (PUBL) | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2017 |
Arterion AB
 Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Vorstandsvorsitzender | 01.08.2013 |
Ausbildung von Rolf Karl Richard Nilsson
| Chalmers University of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACOSENSE AB (PUBL) | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
Parans Solar Lighting AB
 Parans Solar Lighting AB Miscellaneous Commercial ServicesCommercial Services Parans Solar Lighting AB engages in the development and sale of an environmental system. Its products include Parans Luminaire and Parans SP4. The company was founded in 2003 and is headquartered in Moelndal, Sweden. | Commercial Services |
Arterion AB
Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
